Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT03301857
Title Long-term Safety Follow-up of Subjects With Giant Cell Tumor of Bone Treated With Denosumab in Study 20062004
Recruitment Active, not recruiting
Gender both
Phase Phase III
Variant Requirements No
Sponsors Amgen
Indications

bone giant cell tumor

Therapies

Denosumab

Age Groups: adult | senior | child
Covered Countries USA


No variant requirements are available.